According to Fortune Business Insights, the global GLP-1 receptor agonist market was valued at USD 52.08 billion in 2024 and is projected to grow from USD 62.83 billion in 2025 to USD 186.64 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 16.8% during the forecast period. In 2024, North America dominated the market with a 55.51% share.
